|
C16ORF61 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.580600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.500000E-01 |
| Normal-vs-Stage2 |
4.553700E-02 |
| Normal-vs-Stage3 |
4.607600E-02 |
| Normal-vs-Stage4 |
1.454420E-02 |
| Stage1-vs-Stage2 |
1.670220E-02 |
| Stage1-vs-Stage3 |
2.006200E-02 |
| Stage1-vs-Stage4 |
7.362200E-03 |
| Stage2-vs-Stage3 |
9.216400E-04 |
| Stage2-vs-Stage4 |
2.953000E-04 |
| Stage3-vs-Stage4 |
3.559600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.303600E-01 |
| Normal-vs-AfricanAmerican |
9.726200E-02 |
| Normal-vs-Asian |
4.597600E-01 |
| Caucasian-vs-AfricanAmerican |
3.744800E-01 |
| Caucasian-vs-Asian |
7.687200E-01 |
| AfricanAmerican-vs-Asian |
2.658400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.933960E-01 |
| Normal-vs-Female |
7.686600E-01 |
| Male-vs-Female |
1.571010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.553600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.869800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.368000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.897600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.473000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.210000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.958600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.556200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.208200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.384600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.806300E-02 |
| Classical-VS-Follicular |
3.73809999620889E-08 |
| Classical-VS-Other |
9.994000E-01 |
| Classical-VS-Normal |
6.516400E-02 |
| Tall-VS-Follicular |
5.53460000052297E-09 |
| Tall-VS-Other |
3.607400E-01 |
| Tall-VS-Normal |
3.964400E-03 |
| Follicular-VS-Other |
7.970400E-02 |
| Follicular-VS-Normal |
2.103600E-03 |
| Other-VS-Normal |
4.720000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.893000E-01 |
| Normal-vs-N1 |
5.199500E-03 |
| N0-vs-N1 |
3.238800E-04 |
|
|
